Financial reports
10-Q
2024 Q1
Quarterly report
7 Feb 24
10-K
2023 FY
Annual report
27 Nov 23
10-Q
2023 Q3
Quarterly report
8 Aug 23
10-Q
2023 Q2
Quarterly report
9 May 23
10-Q
2023 Q1
Quarterly report
7 Feb 23
10-K/A
2022 FY
Annual report (amended)
27 Jan 23
10-K
2022 FY
Annual report
28 Nov 22
10-Q
2022 Q3
Quarterly report
9 Aug 22
10-Q
2022 Q2
Quarterly report
10 May 22
10-Q
2022 Q1
Quarterly report
9 Feb 22
Current reports
8-K
Submission of Matters to a Vote of Security Holders
24 May 23
8-K
Amendments to Articles of Incorporation or Bylaws
14 Apr 23
8-K
Regulation FD Disclosure
10 Mar 23
8-K
Other Events
7 Feb 23
8-K
Other Events
2 Dec 22
8-K
Submission of Matters to a Vote of Security Holders
27 May 22
8-K
Departure of Directors or Certain Officers
8 Apr 22
8-K
Anavex Life Sciences Announces Change of Auditor to Grant Thornton LLP
4 Mar 22
8-K
Other Events
4 Feb 22
8-K
Regulation FD Disclosure
2 Feb 22
Registration and prospectus
424B5
Prospectus supplement for primary offering
7 Feb 23
S-8
Registration of securities for employees
10 Jun 22
S-3ASR
Automatic shelf registration
24 Sep 21
424B5
Prospectus supplement for primary offering
24 Jun 21
S-8
Registration of securities for employees
9 Apr 21
424B5
Prospectus supplement for primary offering
16 Feb 21
424B5
Prospectus supplement for primary offering
2 Jul 20
424B5
Prospectus supplement for primary offering
1 May 20
424B5
Prospectus supplement for primary offering
1 May 20
POS AM
Prospectus update (post-effective amendment)
17 Sep 19
Proxies
DEFA14A
Additional proxy soliciting materials
4 Apr 23
DEF 14A
Definitive proxy
4 Apr 23
DEFA14A
Additional proxy soliciting materials
11 Apr 22
DEF 14A
Definitive proxy
11 Apr 22
DEF 14A
Definitive proxy
12 Apr 21
PRE 14A
Preliminary proxy
1 Apr 21
DEFA14A
Additional proxy soliciting materials
23 Mar 20
DEF 14A
Definitive proxy
20 Feb 20
DEF 14A
Definitive proxy
11 Feb 19
PRE 14A
Preliminary proxy
31 Jan 19
Other
UPLOAD
Letter from SEC
12 Aug 22
CORRESP
Correspondence with SEC
10 Aug 22
UPLOAD
Letter from SEC
29 Jul 22
EFFECT
Notice of effectiveness
23 Sep 19
EFFECT
Notice of effectiveness
16 Jul 19
CORRESP
Correspondence with SEC
12 Jul 19
UPLOAD
Letter from SEC
11 Jul 19
EFFECT
Notice of effectiveness
12 Jun 17
CORRESP
Correspondence with SEC
9 Jun 17
UPLOAD
Letter from SEC
9 Jun 17
Ownership
4
CHRISTOPHER U MISSLING
1 Apr 24
144
Notice of proposed sale of securities
28 Mar 24
4
Peter D.O. Donhauser
23 Feb 24
4
Steffen Thomas
23 Feb 24
4
Claus Vander Velden
23 Feb 24
4
Jiong Ma
23 Feb 24
4
Athanasios Skarpelos
23 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
BlackRock Inc.
25 Jan 24
SC 13G/A
STATE STREET CORP
22 Jan 24